Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Frank Martin Sacks, M.D.

Co-Author

This page shows the publications co-authored by Frank Sacks and Lu Qi.
Connection Strength

7.026
  1. Low-Fat vs Low-Carbohydrate Diets and Weight Loss. JAMA. 2018 07 10; 320(2):202-203.
    View in: PubMed
    Score: 0.769
  2. Starch Digestion-Related Amylase Genetic Variants, Diet, and Changes in Adiposity: Analyses in Prospective Cohort Studies and a Randomized Dietary Intervention. Diabetes. 2020 09; 69(9):1917-1926.
    View in: PubMed
    Score: 0.219
  3. Genetic Susceptibility, Dietary Protein Intake, and Changes of Blood Pressure: The POUNDS Lost Trial. Hypertension. 2019 12; 74(6):1460-1467.
    View in: PubMed
    Score: 0.210
  4. Lessons Learned from the POUNDS Lost Study: Genetic, Metabolic, and Behavioral Factors Affecting Changes in Body Weight, Body Composition, and Cardiometabolic Risk. Curr Obes Rep. 2019 Sep; 8(3):262-283.
    View in: PubMed
    Score: 0.208
  5. Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial. Diabetes Care. 2019 08; 42(8):1365-1371.
    View in: PubMed
    Score: 0.204
  6. Genetically determined vitamin D levels and change in bone density during a weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial. Am J Clin Nutr. 2018 11 01; 108(5):1129-1134.
    View in: PubMed
    Score: 0.196
  7. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial. Gut. 2019 02; 68(2):263-270.
    View in: PubMed
    Score: 0.191
  8. Genetic, epigenetic and transcriptional variations at NFATC2IP locus with weight loss in response to diet interventions: The POUNDS Lost Trial. Diabetes Obes Metab. 2018 09; 20(9):2298-2303.
    View in: PubMed
    Score: 0.191
  9. A circadian rhythm-related MTNR1B genetic variant modulates the effect of weight-loss diets on changes in adiposity and body composition: the POUNDS Lost trial. Eur J Nutr. 2019 Jun; 58(4):1381-1389.
    View in: PubMed
    Score: 0.188
  10. HNF1A variant, energy-reduced diets and insulin resistance improvement during weight loss: The POUNDS Lost trial and DIRECT. Diabetes Obes Metab. 2018 06; 20(6):1445-1452.
    View in: PubMed
    Score: 0.188
  11. Gut-microbiome-related LCT genotype and 2-year changes in body composition and fat distribution: the POUNDS Lost Trial. Int J Obes (Lond). 2018 09; 42(9):1565-1573.
    View in: PubMed
    Score: 0.187
  12. Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial. Diabetes Care. 2018 03; 41(3):413-419.
    View in: PubMed
    Score: 0.186
  13. Macronutrient-specific effect of the MTNR1B genotype on lipid levels in response to 2 year weight-loss diets. J Lipid Res. 2018 01; 59(1):155-161.
    View in: PubMed
    Score: 0.183
  14. Genetic variation of habitual coffee consumption and glycemic changes in response to weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Am J Clin Nutr. 2017 Nov; 106(5):1321-1326.
    View in: PubMed
    Score: 0.182
  15. Starch Digestion-Related Amylase Genetic Variant Affects 2-Year Changes in Adiposity in Response to Weight-Loss Diets: The POUNDS Lost Trial. Diabetes. 2017 09; 66(9):2416-2423.
    View in: PubMed
    Score: 0.179
  16. Dietary Protein Modifies the Effect of the MC4R Genotype on 2-Year Changes in Appetite and Food Craving: The POUNDS Lost Trial. J Nutr. 2017 03; 147(3):439-444.
    View in: PubMed
    Score: 0.174
  17. Genetic Variations of Circulating Adiponectin Levels Modulate Changes in Appetite in Response to Weight-Loss Diets. J Clin Endocrinol Metab. 2017 01 01; 102(1):316-325.
    View in: PubMed
    Score: 0.173
  18. Macronutrient Intake-Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial. Diabetes Care. 2016 Nov; 39(11):1909-1914.
    View in: PubMed
    Score: 0.169
  19. Plasma Taurine, Diabetes Genetic Predisposition, and Changes of Insulin Sensitivity in Response to Weight-Loss Diets. J Clin Endocrinol Metab. 2016 10; 101(10):3820-3826.
    View in: PubMed
    Score: 0.168
  20. Genetic susceptibility to diabetes and long-term improvement of insulin resistance and ß cell function during weight loss: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Am J Clin Nutr. 2016 Jul; 104(1):198-204.
    View in: PubMed
    Score: 0.166
  21. Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial. J Clin Endocrinol Metab. 2016 Jun; 101(6):2415-22.
    View in: PubMed
    Score: 0.164
  22. Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials. Am J Clin Nutr. 2016 Feb; 103(2):505-11.
    View in: PubMed
    Score: 0.162
  23. Vitamin D metabolism-related genetic variants, dietary protein intake and improvement of insulin resistance in a 2 year weight-loss trial: POUNDS Lost. Diabetologia. 2015 Dec; 58(12):2791-9.
    View in: PubMed
    Score: 0.159
  24. Neuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trial. Am J Clin Nutr. 2015 Aug; 102(2):514-9.
    View in: PubMed
    Score: 0.156
  25. Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial. J Nutr. 2015 Jun; 145(6):1289-94.
    View in: PubMed
    Score: 0.154
  26. Dietary Fat Modifies the Effects of FTO Genotype on Changes in Insulin Sensitivity. J Nutr. 2015 May; 145(5):977-82.
    View in: PubMed
    Score: 0.153
  27. CETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials. J Lipid Res. 2015 Mar; 56(3):713-721.
    View in: PubMed
    Score: 0.151
  28. PCSK7 genotype modifies effect of a weight-loss diet on 2-year changes of insulin resistance: the POUNDS LOST trial. Diabetes Care. 2015 Mar; 38(3):439-44.
    View in: PubMed
    Score: 0.150
  29. FTO genotype, dietary protein, and change in appetite: the Preventing Overweight Using Novel Dietary Strategies trial. Am J Clin Nutr. 2014 May; 99(5):1126-30.
    View in: PubMed
    Score: 0.142
  30. Variants in glucose- and circadian rhythm-related genes affect the response of energy expenditure to weight-loss diets: the POUNDS LOST Trial. Am J Clin Nutr. 2014 Feb; 99(2):392-9.
    View in: PubMed
    Score: 0.140
  31. IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: the POUNDS LOST trial. Diabetes Care. 2013 Nov; 36(11):3442-7.
    View in: PubMed
    Score: 0.137
  32. Genetic determinant for amino acid metabolites and changes in body weight and insulin resistance in response to weight-loss diets: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation. 2013 Mar 26; 127(12):1283-9.
    View in: PubMed
    Score: 0.133
  33. TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention. Am J Clin Nutr. 2012 Nov; 96(5):1129-36.
    View in: PubMed
    Score: 0.129
  34. Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial. Hypertension. 2012 Nov; 60(5):1169-75.
    View in: PubMed
    Score: 0.128
  35. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial. Am J Clin Nutr. 2012 Oct; 96(4):917-22.
    View in: PubMed
    Score: 0.128
  36. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Diabetes. 2012 Nov; 61(11):3005-11.
    View in: PubMed
    Score: 0.128
  37. Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial. Am J Clin Nutr. 2012 Feb; 95(2):506-13.
    View in: PubMed
    Score: 0.123
  38. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation. 2011 Aug 02; 124(5):563-71.
    View in: PubMed
    Score: 0.118
  39. Predicting Weight Loss Using Psychological and Behavioral Factors: The POUNDS LOST Trial. J Clin Endocrinol Metab. 2020 04 01; 105(4).
    View in: PubMed
    Score: 0.054
  40. A Systems Genetics Approach Identified GPD1L and its Molecular Mechanism for Obesity in Human Adipose Tissue. Sci Rep. 2017 05 11; 7(1):1799.
    View in: PubMed
    Score: 0.044
  41. FTO genotype and weight loss: systematic review and meta-analysis of 9563 individual participant data from eight randomised controlled trials. BMJ. 2016 Sep 20; 354:i4707.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.